Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial

Table 2 Schedule of PESAPRO study’s visit

	Visit 1 (Routine control 2 term)^a	Inform Visit	Visit 0 basal (20 weeks + 1 to 23 weeks + 6)	Visit 1 (V0 + 4 weeks)	Visit 2 (V1 + 4 weeks)	Visit 3 (V2 + 4 weeks)	Visit 4 (EOT) (37 weeks to 37 weeks + 4)	Post-delivery visit (4 to 6 weeks post-delivery)
Eligibility criteria		√	√
Informed consent			√
Randomization and start of treatment			√
Blood pressure/ weight			√	√	√	√	√
Vaginal culture			√
Manual vaginal exam			√				√
Cervicometry	√		√	√	√	√	√
Follow-up Questionnaire				√	√	√	√
Basic fetal US			√	√		√	√
End of treatment (EOT)							√
Review maternal medical history			√					√
Review neonate medical history								√

^aThis visit is a routine (“standard of care”) visit in the control of pregnancy. Patients with a short cervix are invited to an extra visit (for information) before being enrolled in the study

ISSN: 1745-6215